Mind & Spirit
Invest in companies transforming mental healthcare through innovative treatments and technologies. These carefully selected stocks represent leaders in psychedelic therapeutics, telehealth platforms, and neurological treatments addressing the growing global demand for mental wellness solutions.
Your Basket's Financial Footprint
Market capitalisation breakdown for the 'Mind & Spirit' basket.
- Large-cap dominance generally implies lower volatility, steadier performance and closer tracking of broad market movements.
- Best used as a core portfolio holding for diversification rather than a speculative, high-growth trade.
- Expect steady, long-term value rather than rapid, explosive gains; growth tends to be gradual.
HIMS: $11.16B
TDOC: $1.53B
CMPS: $623.62M
- Other
About This Group of Stocks
Our Expert Thinking
This collection targets the rapidly expanding mental health market by focusing on companies developing breakthrough treatments and technologies. From novel psychedelic compounds to telehealth services, these stocks represent the future of brain and emotional wellness in an increasingly destigmatized field.
What You Need to Know
This portfolio blends emerging biotechs with established medical companies creating next-generation mental health treatments. The group benefits from powerful trends including regulatory evolution, virtual care adoption, and growing acceptance of alternative therapies for psychological conditions.
Why These Stocks
We've handpicked companies with clear missions to advance mental healthcare through innovation. This selection includes both pioneering startups developing novel compounds and established firms with strong market positions, all poised to address large, underserved patient populations.
Why You'll Want to Watch These Stocks
Breaking Mental Health Barriers
These companies are pioneering treatments once considered impossible, creating therapies that could help millions with treatment-resistant conditions like severe depression and PTSD.
Regulatory Winds Shifting
A fundamental change in how regulators view novel therapeutics is quickly unlocking massive new markets, especially for previously restricted compounds showing promise for mental health.
The Next Healthcare Revolution
Mental health is becoming as important as physical health, with spending expected to surge as stigma fades and innovative digital platforms make treatment more accessible than ever before.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Drug Pricing Power | Major Pharma Stocks 2025
Following plans by major drugmakers to raise prices on hundreds of medications, the pharmaceutical industry is showcasing its significant pricing power. This development highlights an investment opportunity centered on established pharmaceutical companies capable of translating market dominance into revenue growth.
Automation & Software Investment Theme Overview
Recent labor data reveals a split market, with low private-sector jobless claims contrasting with high unemployment driven by federal layoffs. This dynamic creates an investment opportunity in companies providing automation, software, and efficiency-boosting services as businesses prioritize productivity over expanding their payrolls.
Oyo's IPO Plans: Hospitality Sector Recovery Explained
Global hospitality firm Oyo's parent company has revived its IPO plans, signaling renewed confidence in the travel market. This high-profile listing could ignite investor interest across the entire hospitality and travel technology sector, creating opportunities for related service providers.